Warning: Declaration of about_menu_walker::start_lvl(&$output, $depth) should be compatible with Walker_Page::start_lvl(&$output, $depth = 0, $args = Array) in /home/hyperte/public_html/content/themes/blh/functions.php on line 271

Warning: Declaration of about_menu_walker::start_el(&$output, $page, $depth, $args, $current_page = 0) should be compatible with Walker_Page::start_el(&$output, $page, $depth = 0, $args = Array, $current_page = 0) in /home/hyperte/public_html/content/themes/blh/functions.php on line 275

Warning: Declaration of description_walker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $item, $depth = 0, $args = Array, $id = 0) in /home/hyperte/public_html/content/themes/blh/functions.php on line 337
VIEW THE JUNE ISSUE – ISH HYPERTENSION NEWS « Българска Лига по Хипертония

VIEW THE JUNE ISSUE – ISH HYPERTENSION NEWS

VIEW THE JUNE ISSUE – ISH HYPERTENSION NEWS

image

June 2017

VIEW THE JUNE ISSUE – ISH HYPERTENSION NEWS

Apologies, the compressed PDF version link was incorrect in the previous email you recieved. If you would like to view the June compressed version, please use the link below.

Contributions:

 

  • President’s Report: Neil Poulter updates on our unique and exciting global health campaign – May Measurement Month (MMM17)
  • The Secretary’s Voice: The ISH Secretary, Maciej Tomaszewski, gives you insights into the outcomes of recent ISH activities, the status of current undertakings, and future outlooks.
  • Hot off the Press reports: (1) Is successful renal denervation a function of adherence to antihypertensive medication? (2) From RAG to Riches And Back Again: always keep an eye on our mice models (3) Podocyte specific APOL1 risk variant overexpression in mice induces proteinuric kidney disease
  • Assessing adherence to prescribed drug treatment, or as Thomas Kahan puts it in his introductory remark: “Is Adherence to Medication the Elephant in the Room?” Needless to say, we all need to pay (more) attention to patient adherence to improve blood pressure control. Drug analyses may be one way of doing it! Apart from the Introduction, we present three papers on this topic, each with a
    different focus: one on the use of registries, a second on clinical aspects, and a third on ethics.
  • Lipid Lowering in the Hypertensive Patient: Since hypertension and dyslipidaemia often co-exist I recommend that you read Peter Sever’s balanced report on the results of the FOURIER trial, comparing evolocumab and placebo in 27,500 patients with established CVD and recently published in the NEJM.
  • Award winners: ISH funding for mentors and organisations to train research scholars in hypertension research
  • New Investigator spotlight features – March to June 2017
  • Council’s Corner: Nadia Khan shares her views in a report entitled „Expanding the workforce in hypertension: A Focus on Pharmacists“ 
  • SAHA and IASH, Mendoza meeting reports
  • Facts about ISH membership

My sincere thanks to all those who have made these invaluable contributions to this issue of Hypertension News.

Have a good read!

image

Lars H. Lindholm

Editor, ISH Hypertension News

ISH Secretariat

c/o The Conference Collective Ltd

 

UK – Tel: +44 (0) 20 8977 7997

W: www.ish-world.com

E: secretariat@ish-world.com

Facebook Twitter LinkedIn YouTube

8
Waldegrave Road | Teddington | Middlesex TW11 8GT | UK

Registered charity number: 1122135